CBX3P6

Across TCGA pan-cancer cohorts, CBX3P6 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CBX3P6’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where CBX3P6 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CBX3P6 is over-expressed in tumor.

LUSC, LIHC, and BRCA are the cancer types where CBX3P6 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CBX3P6 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	+0.044	.006	2	view →
LIHC	All	All	+0.041	.011	2	view →
BRCA	All	All	+0.037	.015	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

CBX3P6–LUSC

Open the LUSC breakdown →